IDEAYA reports Phase 1 expansion data for IDE397

IDEAYA reports Phase 1 expansion data for IDE397

Submitted by admin on October 27, 2024 - 7:45pm
Source: 
MSN/Seeking Alpha
News Tags: 
Ideaya
clinical trials
IDE397
MTAP
urothelial cancer
lung cancer
Headline: 
IDEAYA reports Phase 1 expansion data for IDE397
snippet: 

IDEAYA (NASDAQ:IDYA) reported positive interim Phase 1 expansion data for its drug candidate IDE397 in the treatment of MTAP-deletion urothelial and lung cancer.

Do Not Allow Advertisers to Use My Personal information